Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: Strong Long who wrote (1862)	4/19/2016 3:23:34 PM
From: Mirror Image	Read Replies (2) \| Respond to of 2026

Yeah, Forendo is who comes to mind. They are going to continue working with Fispemifene and will need money to keep it going ( I'm sure ). Although I must say that they are slowly walking the PPS. We are certainly witnessing increased volume, but it's a orderly exit on one side and a slow accumulation on the other - In my opinion. Who knows - maybe now that I posted my opinion - the market will prove me wrong and the share price will drop. I must say that I have two decent buys GTC put in at very close levels from here. I already have too many shares - but if they want to walk the PPS lower - they will have to fill my buys.